{"id":"https://openalex.org/W2139203507","doi":"https://doi.org/10.1212/wnl.0b013e31827b1af6","title":"Emerging Subspecialties in Neurology: Clinical development","display_name":"Emerging Subspecialties in Neurology: Clinical development","publication_year":2012,"publication_date":"2012-12-24","ids":{"openalex":"https://openalex.org/W2139203507","doi":"https://doi.org/10.1212/wnl.0b013e31827b1af6","mag":"2139203507","pmid":"https://pubmed.ncbi.nlm.nih.gov/23267036"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0b013e31827b1af6","doi":"https://doi.org/10.1212/wnl.0b013e31827b1af6","is_oa":true,"landing_page_url":"https://doi.org/10.1212/wnl.0b013e31827b1af6","pdf_url":"https://n.neurology.org/content/neurology/80/1/e4.full.pdf","source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://n.neurology.org/content/neurology/80/1/e4.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049165680","display_name":"Jeffrey T. Guptill","orcid":"https://orcid.org/0000-0002-0312-0716","observed_orcids":["https://orcid.org/0000-0002-0312-0716"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey T. Guptill","raw_affiliation_strings":["From Duke Clinical Research Institute (J.T.G.), Durham; Division of Pharmacotherapy and Experimental Therapeutics (R.E.D.), Eshelman School of Pharmacy, University of North Carolina, Chapel Hill; and UCB Pharma Inc (O.D.), Raleigh, NC","From Duke Clinical Research Institute (J.T.G.), Durham","UCB Pharma Inc (O.D.), Raleigh, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Duke Clinical Research Institute (J.T.G.), Durham; Division of Pharmacotherapy and Experimental Therapeutics (R.E.D.), Eshelman School of Pharmacy, University of North Carolina, Chapel Hill; and UCB Pharma Inc (O.D.), Raleigh, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I170897317","https://openalex.org/I4405286153"]},{"raw_affiliation_string":"From Duke Clinical Research Institute (J.T.G.), Durham","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"UCB Pharma Inc (O.D.), Raleigh, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113874155","display_name":"Robert E. Dupuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert E. Dupuis","raw_affiliation_strings":["From Duke Clinical Research Institute (J.T.G.), Durham; Division of Pharmacotherapy and Experimental Therapeutics (R.E.D.), Eshelman School of Pharmacy, University of North Carolina, Chapel Hill; and UCB Pharma Inc (O.D.), Raleigh, NC","From Duke Clinical Research Institute (J.T.G.), Durham","UCB Pharma Inc (O.D.), Raleigh, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Duke Clinical Research Institute (J.T.G.), Durham; Division of Pharmacotherapy and Experimental Therapeutics (R.E.D.), Eshelman School of Pharmacy, University of North Carolina, Chapel Hill; and UCB Pharma Inc (O.D.), Raleigh, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I170897317","https://openalex.org/I4405286153"]},{"raw_affiliation_string":"From Duke Clinical Research Institute (J.T.G.), Durham","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"UCB Pharma Inc (O.D.), Raleigh, NC","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109255186","display_name":"O\u2019Neill D\u2019Cruz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"O\u2019Neill D\u2019Cruz","raw_affiliation_strings":["From Duke Clinical Research Institute (J.T.G.), Durham; Division of Pharmacotherapy and Experimental Therapeutics (R.E.D.), Eshelman School of Pharmacy, University of North Carolina, Chapel Hill; and UCB Pharma Inc (O.D.), Raleigh, NC","From Duke Clinical Research Institute (J.T.G.), Durham","UCB Pharma Inc (O.D.), Raleigh, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From Duke Clinical Research Institute (J.T.G.), Durham; Division of Pharmacotherapy and Experimental Therapeutics (R.E.D.), Eshelman School of Pharmacy, University of North Carolina, Chapel Hill; and UCB Pharma Inc (O.D.), Raleigh, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I170897317","https://openalex.org/I4405286153"]},{"raw_affiliation_string":"From Duke Clinical Research Institute (J.T.G.), Durham","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"UCB Pharma Inc (O.D.), Raleigh, NC","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.17837157,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"1","first_page":"e4","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.6919000148773193,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.6919000148773193,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.1331000030040741,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.021299999207258224,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.8679999709129333},{"id":"https://openalex.org/keywords/neurology-subspecialties","display_name":"neurology subspecialties","score":0.7889999747276306},{"id":"https://openalex.org/keywords/investigational-new-drug-application","display_name":"Investigational New Drug application","score":0.8259999752044678},{"id":"https://openalex.org/keywords/clinical-trial-phases","display_name":"clinical trial phases","score":0.7440000176429749},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.8309999704360962},{"id":"https://openalex.org/keywords/medical-device-development","display_name":"medical device development","score":0.8169999718666077},{"id":"https://openalex.org/keywords/post-marketing-studies","display_name":"post-marketing studies","score":0.6620000004768372},{"id":"https://openalex.org/keywords/drug-registration","display_name":"drug registration","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C2910824759","wikidata":"https://www.wikidata.org/wiki/Q6060674","display_name":"Investigational Drugs","level":3,"score":0.6749547719955444},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6746835708618164},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.6719180941581726},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.64839768409729},{"id":"https://openalex.org/C2776876202","wikidata":"https://www.wikidata.org/wiki/Q1368197","display_name":"New drug application","level":3,"score":0.46813663840293884},{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.4266057014465332},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27661991119384766},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24046459794044495},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13271838426589966}],"mesh":[{"descriptor_ui":"D004651","descriptor_name":"Employment","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D005257","descriptor_name":"Fellowships and Scholarships","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008511","descriptor_name":"Medicine","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D009462","descriptor_name":"Neurology","qualifier_ui":"Q000193","qualifier_name":"education","is_major_topic":false},{"descriptor_ui":"D009462","descriptor_name":"Neurology","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000193","qualifier_name":"education","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1212/wnl.0b013e31827b1af6","doi":"https://doi.org/10.1212/wnl.0b013e31827b1af6","is_oa":true,"landing_page_url":"https://doi.org/10.1212/wnl.0b013e31827b1af6","pdf_url":"https://n.neurology.org/content/neurology/80/1/e4.full.pdf","source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},{"id":"pmid:23267036","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23267036","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1212/wnl.0b013e31827b1af6","doi":"https://doi.org/10.1212/wnl.0b013e31827b1af6","is_oa":true,"landing_page_url":"https://doi.org/10.1212/wnl.0b013e31827b1af6","pdf_url":"https://n.neurology.org/content/neurology/80/1/e4.full.pdf","source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.41999998688697815,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139203507.pdf","grobid_xml":"https://content.openalex.org/works/W2139203507.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1605325722","https://openalex.org/W2084695029","https://openalex.org/W2152158712","https://openalex.org/W2163623879","https://openalex.org/W2327776387","https://openalex.org/W2514453435","https://openalex.org/W2724439314"],"related_works":["https://openalex.org/W7098121591","https://openalex.org/W7127903495","https://openalex.org/W2736993007","https://openalex.org/W1666204429","https://openalex.org/W4407027388","https://openalex.org/W2495323844","https://openalex.org/W4240263666","https://openalex.org/W4231386512","https://openalex.org/W595861982","https://openalex.org/W2410171397"],"abstract_inverted_index":{"Therapeutic":[0],"development":[1,24],"includes":[2],"the":[3,48,52,62,118],"activities":[4],"necessary":[5],"to":[6,18,98],"bring":[7],"a":[8,26,56,67,94],"new":[9,27,68],"medicinal":[10],"compound":[11],"(chemical":[12],"or":[13,15,23],"biologic)":[14],"medical":[16],"device":[17],"market.":[19],"Following":[20],"drug":[21],"discovery":[22],"of":[25,66,117],"device,":[28],"successful":[29],"preclinical":[30],"studies":[31],"result":[32],"in":[33,47,70,91],"an":[34],"Investigational":[35],"New":[36],"Drug":[37],"(IND)":[38],"application":[39],"(United":[40],"States":[41],"only;":[42],"Clinical":[43],"Trials":[44],"Exemption":[45],"Certificate":[46],"United":[49],"Kingdom).":[50],"Once":[51],"IND":[53],"is":[54],"filed,":[55],"team-driven":[57],"process":[58],"begins":[59],"that":[60],"tests":[61],"efficacy":[63],"and":[64,100,109],"safety":[65],"therapeutic":[69],"humans.":[71],"This":[72],"process,":[73],"known":[74],"as":[75],"clinical":[76],"development,":[77],"has":[78],"traditionally":[79],"been":[80],"divided":[81],"into":[82],"4":[83],"phases,":[84],"with":[85,93],"large-scale":[86],"phase":[87],"3":[88],"pivotal":[89],"trials":[90],"patients":[92],"specific":[95],"disease":[96],"leading":[97],"registration":[99],"postmarketing":[101],"studies.1":[102],"The":[103],"authors":[104],"thank":[105],"Daniel":[106],"Benjamin,":[107],"MD,":[108,112],"Paul":[110],"Watkins,":[111],"for":[113],"their":[114],"critical":[115],"review":[116],"manuscript.":[119]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}